PSA’s up-to-date COVID-19 advice for pharmacists

As the number of COVID-19 cases continues to rise in Australia, PSA is working to ensure pharmacists’ needs are considered in pandemic planning.

Managing gastrointestinal problems in infants

        Opting for a better approach. Proton pump inhibitors (PPIs) were developed in the 1980s. Omeprazole, the first to be marketed, is on the WHO Model...

Hand in hand: Healthcare benefits of GP pharmacists 

The emerging role for Australian pharmacists working in general practices is seen by many pharmacists as an exciting new career opportunity. It is supported...

Future health series: pharmacy can adjust the sails

It’s no longer plain sailing in Australian community pharmacy. Bruce Annabel helps navigate in this, the fourth instalment of our Future Health series. Most...

Pharmacist stress in the pandemic

Managing an increased workload, medicine shortages, myriad legislation changes, reduced staff numbers and an anxious public has seen pharmacists' stress levels rise.

Breaking the silence on mental health

Annette Baker, whose portrait was one of 49 finalists in the inaugural Australian Mental Health Prize 2016, has worked hard to raise awareness about...